Adaptive Biotechnologies CorporationADPTNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank63
3Y CAGR-3.2%
5Y CAGR+8.6%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-3.2%/yr
vs +42.3%/yr prior
5Y CAGR
+8.6%/yr
Recent deceleration
Acceleration
-45.5pp
Decelerating
Percentile
P63
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$167.27M+6.2%
2024$157.56M-8.7%
2023$172.51M-6.3%
2022$184.13M+8.3%
2021$169.97M+53.3%
2020$110.89M+61.2%
2019$68.78M+53.2%
2018$44.90M+37.2%
2017$32.71M-